Olivier Gouédard
Chief Operating Officer at Cytovia Therapeutics, Inc.
Profile
Olivier Gouédard is currently the Chief Operating Officer at Cytovia Therapeutics, Inc. He holds an MBA from New York University, a doctorate from the University of Rennes, and an undergraduate degree from Université Paris-Saclay.
Olivier Gouédard active positions
Companies | Position | Start |
---|---|---|
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Chief Operating Officer | 2021-06-21 |
Training of Olivier Gouédard
New York University | Masters Business Admin |
Université Paris-Saclay | Undergraduate Degree |
University of Rennes | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Olivier Gouédard